---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-022283"
form_type: "8-K"
ticker: "CODX"
cik: "0001692415"
company_name: "Co-Diagnostics, Inc."
filed_at: "2025-11-13T23:59:59+00:00"
generated_at: "2026-05-16T20:27:30.758120+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Co-Diagnostics Q3 net loss narrows to $5.9M; announces JV in Saudi Arabia and SPAC exploration for India unit

## Summary
- Revenue $0.1M, down from $0.6M YoY; net loss $5.9M ($0.16/share) vs $9.7M ($0.32) in Q3 2024.
- Operating loss $7.0M vs $10.2M; adjusted EBITDA loss $6.3M.
- Cash and marketable securities $11.4M at Sept 30, 2025.
- Signed JV with Arabian Eagle Manufacturing for CoMira Diagnostics in KSA and 18 MENA nations.
- Engaged Maxim Group to pursue SPAC transaction for CoSara India JV; closed RDOs totaling ~$10.8M gross.

## SEC filing metadata
- accession: 0001493152-25-022283
- form_type: 8-K
- ticker: CODX
- cik: 0001692415
- company_name: Co-Diagnostics, Inc.
- filed_at: 2025-11-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1692415/000149315225022283/0001493152-25-022283-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1692415/000149315225022283/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-022283
- JSON: https://secwatch.observer/filing/0001493152-25-022283.json
- Plain text: https://secwatch.observer/filing/0001493152-25-022283.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.